Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Valin

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Scandinavian Journal of Infectious Diseases|March 13, 2010
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patientsFabienne Caby, Nadia Valin, Anne Genevieve Marcelin, et al.
International Journal of Antimicrobial Agents|June 14, 2019
Uncommon Detection of Mixed HCV Genotype Infections in Recently Infected Men Who Have Sex with MenThuy Nguyen, Constance Delaugerre, Marc-Antoine Valantin, et al.
Plos One|March 26, 2014
Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan regionJulie Bottero, Anders Boyd, Maud Lemoine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2024
Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with Lenacapavir-Containing RegimenThomas Montrouge, Mélanie Bertine, Gilles Peytavin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected IndividualsEdouard Januel, Ophelia Godin, Antoine Moulignier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2017
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected IndividualsAntoine Moulignier, Julien Savatovsky, Lambert Assoumou, et al.
AIDS (London, England)|June 22, 2022
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2Valérie Pourcher, Lisa Belin, Cathia Soulie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2019
Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure ProphylaxisPierre Gantner, Mojgan Hessamfar, Mohamed Faouzi Souala, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Scandinavian Journal of Infectious Diseases|March 13, 2010
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patientsFabienne Caby, Nadia Valin, Anne Genevieve Marcelin, et al.
International Journal of Antimicrobial Agents|June 14, 2019
Uncommon Detection of Mixed HCV Genotype Infections in Recently Infected Men Who Have Sex with MenThuy Nguyen, Constance Delaugerre, Marc-Antoine Valantin, et al.
Plos One|March 26, 2014
Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan regionJulie Bottero, Anders Boyd, Maud Lemoine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2024
Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with Lenacapavir-Containing RegimenThomas Montrouge, Mélanie Bertine, Gilles Peytavin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected IndividualsEdouard Januel, Ophelia Godin, Antoine Moulignier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2017
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected IndividualsAntoine Moulignier, Julien Savatovsky, Lambert Assoumou, et al.
AIDS (London, England)|June 22, 2022
High seroconversion rate and SARS-CoV-2 Delta neutralization in people with HIV vaccinated with BNT162b2Valérie Pourcher, Lisa Belin, Cathia Soulie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2019
Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure ProphylaxisPierre Gantner, Mojgan Hessamfar, Mohamed Faouzi Souala, et al.
Pageof 6